Accent Capital Management, LLC Verastem, Inc. Transaction History
Accent Capital Management, LLC
- $173 Billion
- Q1 2025
A detailed history of Accent Capital Management, LLC transactions in Verastem, Inc. stock. As of the latest transaction made, Accent Capital Management, LLC holds 52 shares of VSTM stock, worth $403. This represents 0.0% of its overall portfolio holdings.
Number of Shares
52Holding current value
$403% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding VSTM
# of Institutions
6Shares Held
297KCall Options Held
0Put Options Held
0-
Telemetry Investments, L.L.C. New York, NY225KShares$1.75 Million0.14% of portfolio
-
Beaumont Financial Partners, LLC48KShares$372,4800.0% of portfolio
-
Eaton Vance Management Boston, MA20KShares$155,2000.0% of portfolio
-
American Portfolios Advisors Holbrook, NY2.99KShares$23,1630.0% of portfolio
-
Brewin Dolphin Wealth Management LTD Conskleagh, Dublin, L21.07KShares$8,3340.0% of portfolio
About Verastem, Inc.
- Ticker VSTM
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 210,000,000
- Market Cap $1.63B
- Description
- Verastem, Inc., a development-stage biopharmaceutical company, focusing on developing and commercializing drugs for the treatment of cancer. Its product in development includes VS-6766, a dual rapidly accelerated fibrosarcoma (RAF)/mitogen-activated protein kinase (MEK) clamp that blocks MEK kinase activity and the ability of RAF to phosphorylat...